If you have been told you might have PCOS or you are going through irregular periods and other symptoms, your doctor will ...

Withdrawn to 2026, one thing is indisputable: preventive healthcare is not just an alternative anymore; it's the wisest ...

Prostate cancer is still associated with fear and social stigma, despite being the second most common cancer among men and one that needs attention. A urologist explained that advances in treatment ...

Following their appointment, patients receive swift digital results that can be easily shared with GPs and consultants - whether NHS or private - with the option to request copies of their scans if ...

RICHMOND, Va. (WRIC) — Virginia Commonwealth University’s (VCU) Massey Comprehensive Cancer Center in Richmond is the first site in Virginia to offer a new non-surgical robotic ultrasound procedure ...

New Publication Shows PROSTOX™ ultra Test Delivers Significant Health System Cost Savings and Quality-of-Life Gains for Prostate Cancer Patients Undergoing Radiation Therapy MiraDx, a molecular ...

Dec. 15, 2025 — For decades, when tests suggested that a man might have prostate cancer, the next step was usually a biopsy. The procedure, where a doctor uses a thin needle to collect prostate ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Cleveland Diagnostics is ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...

The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...